410 related articles for article (PubMed ID: 15712375)
21. Male breast cancer in the veterans affairs population: a comparative analysis.
Nahleh ZA; Srikantiah R; Safa M; Jazieh AR; Muhleman A; Komrokji R
Cancer; 2007 Apr; 109(8):1471-7. PubMed ID: 17342768
[TBL] [Abstract][Full Text] [Related]
22. Clinicopathologic features and long-term outcome of patients with medullary breast carcinoma managed with breast-conserving therapy (BCT).
Vu-Nishino H; Tavassoli FA; Ahrens WA; Haffty BG
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1040-7. PubMed ID: 15990007
[TBL] [Abstract][Full Text] [Related]
23. The replication error phenotype is associated with the development of distant metastases in hormonally treated patients with breast carcinoma.
Chagpar A; Magliocco A; Kerviche A; Tan L; Walley B; DeCoteau JF
Cancer; 2004 Mar; 100(5):913-9. PubMed ID: 14983485
[TBL] [Abstract][Full Text] [Related]
24. Timing of familial breast cancer in sisters.
Rebora P; Czene K; Reilly M
J Natl Cancer Inst; 2008 May; 100(10):721-7. PubMed ID: 18477799
[TBL] [Abstract][Full Text] [Related]
25. Risk factors for development of subclinical hypothyroidism during valproic acid therapy.
Mikati MA; Tarabay H; Khalil A; Rahi AC; El Banna D; Najjar S
J Pediatr; 2007 Aug; 151(2):178-81. PubMed ID: 17643774
[TBL] [Abstract][Full Text] [Related]
26. The risk of multiple primary breast and thyroid carcinomas.
Adjadj E; Rubino C; Shamsaldim A; Lê MG; Schlumberger M; de Vathaire F
Cancer; 2003 Sep; 98(6):1309-17. PubMed ID: 12973856
[TBL] [Abstract][Full Text] [Related]
27. Older women with breast carcinoma are less likely to receive adjuvant chemotherapy: evidence of possible age bias?
Woodard S; Nadella PC; Kotur L; Wilson J; Burak WE; Shapiro CL
Cancer; 2003 Sep; 98(6):1141-9. PubMed ID: 12973837
[TBL] [Abstract][Full Text] [Related]
28. Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
Chlebowski RT; Anderson GL; Lane DS; Aragaki AK; Rohan T; Yasmeen S; Sarto G; Rosenberg CA; Hubbell FA;
J Natl Cancer Inst; 2007 Nov; 99(22):1695-705. PubMed ID: 18000216
[TBL] [Abstract][Full Text] [Related]
29. Is mode of breast cancer detection associated with cancer treatment in the United States?
Yabroff KR; Harlan LC; Clegg LX; Ballard-Barbash R; Stevens J; Weaver DL
Cancer; 2008 Mar; 112(5):1011-9. PubMed ID: 18189297
[TBL] [Abstract][Full Text] [Related]
30. Thyroid function in women after multimodal treatment for breast cancer stage II/III: comparison with controls from a population sample.
Reinertsen KV; Cvancarova M; Wist E; Bjøro T; Dahl AA; Danielsen T; Fosså SD
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):764-70. PubMed ID: 19286332
[TBL] [Abstract][Full Text] [Related]
31. Epidemiology and economic burden of brain metastases among patients with primary breast cancer: results from a US claims data analysis.
Pelletier EM; Shim B; Goodman S; Amonkar MM
Breast Cancer Res Treat; 2008 Mar; 108(2):297-305. PubMed ID: 17577662
[TBL] [Abstract][Full Text] [Related]
32. Socioeconomic status, immigration/acculturation, and ethnic variations in breast conserving surgery, San Francisco Bay area.
Gomez SL; France AM; Lee MM
Ethn Dis; 2004; 14(1):134-40. PubMed ID: 15002933
[TBL] [Abstract][Full Text] [Related]
33. Obesity and outcomes in premenopausal and postmenopausal breast cancer.
Loi S; Milne RL; Friedlander ML; McCredie MR; Giles GG; Hopper JL; Phillips KA
Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1686-91. PubMed ID: 16030102
[TBL] [Abstract][Full Text] [Related]
34. Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by Paclitaxel for early breast cancer.
Martín M; Rodríguez-Lescure A; Ruiz A; Alba E; Calvo L; Ruiz-Borrego M; Munárriz B; Rodríguez CA; Crespo C; de Alava E; López García-Asenjo JA; Guitián MD; Almenar S; González-Palacios JF; Vera F; Palacios J; Ramos M; Gracia Marco JM; Lluch A; Alvarez I; Seguí MA; Mayordomo JI; Antón A; Baena JM; Plazaola A; Modolell A; Pelegrí A; Mel JR; Aranda E; Adrover E; Alvarez JV; García Puche JL; Sánchez-Rovira P; Gonzalez S; López-Vega JM;
J Natl Cancer Inst; 2008 Jun; 100(11):805-14. PubMed ID: 18505968
[TBL] [Abstract][Full Text] [Related]
35. Increased prevalence of thyroid autoimmunity and hypothyroidism in patients with glycogen storage disease type I.
Melis D; Pivonello R; Parenti G; Della Casa R; Salerno M; Lombardi G; Sebastio G; Colao A; Andria G
J Pediatr; 2007 Mar; 150(3):300-5, 305.e1. PubMed ID: 17307551
[TBL] [Abstract][Full Text] [Related]
36. Risk of hypothyroidism in older breast cancer patients treated with radiation.
Smith GL; Smith BD; Giordano SH; Shih YC; Woodward WA; Strom EA; Perkins GH; Tereffe W; Yu TK; Buchholz TA
Cancer; 2008 Mar; 112(6):1371-9. PubMed ID: 18213620
[TBL] [Abstract][Full Text] [Related]
37. A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma.
Di Saverio S; Gutierrez J; Avisar E
Breast Cancer Res Treat; 2008 Oct; 111(3):541-7. PubMed ID: 18026874
[TBL] [Abstract][Full Text] [Related]
38. Thyroid hormones and duration of ovulatory activity in the etiology of breast cancer.
Morabia A; Szklo M; Stewart W; Schuman L; Thomas DB; Zacur HA
Cancer Epidemiol Biomarkers Prev; 1992; 1(5):389-93. PubMed ID: 1305472
[TBL] [Abstract][Full Text] [Related]
39. Subclinical hypothyroidism and pregnancy outcomes.
Casey BM; Dashe JS; Wells CE; McIntire DD; Byrd W; Leveno KJ; Cunningham FG
Obstet Gynecol; 2005 Feb; 105(2):239-45. PubMed ID: 15684146
[TBL] [Abstract][Full Text] [Related]
40. Influence of delay to diagnosis on prognostic indicators of screen-detected breast carcinoma.
Olivotto IA; Gomi A; Bancej C; Brisson J; Tonita J; Kan L; Mah Z; Harrison M; Shumak R
Cancer; 2002 Apr; 94(8):2143-50. PubMed ID: 12001110
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
